Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
 
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82
News

Investors cheer IDBI Banks revival plan; Stock trades green

India Infoline News Service May-26-2017

he state-owned IDBI Bank Limited has come up with plans for capital raising and recovery from non-performing assets.

Live Stock Market Updates: Nifty hovers around 9545; Bank Nifty holds Thursdays rally

India Infoline News Service May-26-2017

he INDIA VIX is up 4% at 10.8. BSE Sensex is trading at 30887 up 137 points, while NSE Nifty is trading at 9548 up 38 points.

Jubilant Life Sciences hikes price of Vitamin B3 (Niacin and Niacinamide) by 15 %

India Infoline News Service May-26-2017

ubilant Life Sciences, an Indian pharma firm, on Thursday, announced the increase of prices for Vitamin B3 (Niacin and Niacinamide) by 15% with immediate effect.

Cipla drops below 2% as it reports quarterly loss

India Infoline News Service May-26-2017

ipla on Thursday posted a consolidated net loss of Rs 61.79 crore for the quarter ended March 31, 2017. The company had posted a consolidated net loss of Rs 92.83 crore for the same quarter in the previous year.

Vedanta replaces Grasim in the Nifty 50 index

India Infoline News Service May-26-2017

edanta Limited, a flagship company of the Vedanta Group has made its place in the Nifty50 index, on the other hand, the Grasim Industries Limited, building materials producing company has been excluded from the index.

Granules India to infuse Rs 220 crore to push the expansion of its US-based subsidiary

India Infoline News Service May-26-2017

ranules India Limited the Hyderabad-based company is going to expand its operations of its wholly owned US-based subsidiary Granules Pharmaceuticals Inc. The pharma giant will be investing $35 million (Rs 220 crore) on the expansion.

welcome to iifl